Stock Analysis

Three Undiscovered Gems in the United States Market

Published

The market is up 3.1% over the last week, with the Information Technology sector up 4.6%. Over the past 12 months, the market is up 25%, and earnings are forecast to grow by 15% annually. In this thriving environment, identifying stocks with strong fundamentals and growth potential can lead to significant opportunities for investors.

Top 10 Undiscovered Gems With Strong Fundamentals In The United States

NameDebt To EquityRevenue GrowthEarnings GrowthHealth Rating
Morris State Bancshares10.20%-0.32%6.73%★★★★★★
River Financial122.41%16.43%18.50%★★★★★★
Mission Bancorp25.37%16.23%20.16%★★★★★★
TeekayNA-6.48%55.79%★★★★★★
First Northern Community BancorpNA7.12%10.04%★★★★★★
Omega FlexNA1.31%3.88%★★★★★★
Valhi38.71%2.57%-19.76%★★★★★☆
Tiptree68.59%20.55%20.06%★★★★★☆
Village Super Market17.52%6.27%19.60%★★★★☆☆
FRMO0.17%12.99%23.62%★★★★☆☆

Click here to see the full list of 222 stocks from our US Undiscovered Gems With Strong Fundamentals screener.

Let's uncover some gems from our specialized screener.

Helport AI (NasdaqCM:HPAI)

Simply Wall St Value Rating: ★★★★★☆

Overview: Helport AI Limited is an AI technology company that offers intelligent products, solutions, and a digital platform to enhance business-to-customer communication and sales performance, with a market cap of $317.57 million.

Operations: Helport AI generates revenue primarily from its Software & Programming segment, totaling $21.31 million. The company has a market cap of $317.57 million.

Helport AI, a small cap stock, has shown impressive growth with earnings increasing by 208% over the past year, outpacing the Software industry’s 23%. Its net debt to equity ratio stands at a satisfactory 4.5%, and interest payments are well covered by EBIT at 403.5x coverage. Recently added to the NASDAQ Composite Index on August 6, Helport AI trades at a significant discount of 88% below its estimated fair value despite high volatility in share price over the last three months.

NasdaqCM:HPAI Earnings and Revenue Growth as at Aug 2024

RedHill Biopharma (NasdaqCM:RDHL)

Simply Wall St Value Rating: ★★★★★☆

Overview: RedHill Biopharma Ltd. is a specialty biopharmaceutical company that primarily focuses on gastrointestinal and infectious diseases, with a market cap of $256.99 million.

Operations: RedHill Biopharma Ltd. derives its revenue from the sale of specialty biopharmaceutical products targeting gastrointestinal and infectious diseases. The company has a market cap of $256.99 million.

RedHill Biopharma, a small cap stock, recently reported a significant one-off gain of US$54.6M for the year ending December 31, 2023. The company is debt-free and has maintained this status for over five years. Despite becoming profitable last year, its share price has been highly volatile over the past three months. Recent developments include the launch of Talicia in the UAE and positive results from studies on opaganib for Type 2 diabetes treatment.

NasdaqCM:RDHL Earnings and Revenue Growth as at Aug 2024

Hovnanian Enterprises (NYSE:HOV)

Simply Wall St Value Rating: ★★★★★☆

Overview: Hovnanian Enterprises, Inc., through its subsidiaries, designs, constructs, markets, and sells residential homes in the United States with a market cap of $1.18 billion.

Operations: Hovnanian Enterprises generates revenue primarily from its homebuilding operations in the West ($1.35 billion), Northeast ($935.87 million), and Southeast ($480.25 million) regions, along with financial services contributing $66.16 million.

Hovnanian Enterprises has shown promising performance, with earnings growing by 20.3% over the past year, surpassing the Consumer Durables industry growth of 0.5%. The company’s interest payments are well covered by EBIT at 6.5 times coverage, indicating strong financial health despite a high net debt to equity ratio of 141.9%. Recently added to multiple Russell indices and completing a significant share buyback program (10.52% for US$36.82 million), Hovnanian's outlook appears robust amidst its high-quality earnings and strategic repurchases.

NYSE:HOV Debt to Equity as at Aug 2024

Make It Happen

Contemplating Other Strategies?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com